Bone Therapeutics Business Update for Third Quarter 2018
GlobeNewswire (press release)
Cell therapy development programmes to be focused fully on ALLOB platform following DSMB recommendation to discontinue PREOB trial in osteonecrosis of the hip. Gosselies, Belgium, 7 November 2018, 7am CET – BONE THERAPEUTICS (Euronext …

X